We are live on ! Find out more
ASTX

ASTEX PHARMACEUTICALS, INC COM
ASTX

Delisted

ASTX was delisted on the 10th of October, 2013.

Back to rankings

0 hedge funds and large institutions have $0 invested in ASTEX PHARMACEUTICALS, INC COM in 2013 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 123 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 123 → 0 (-123)

100% less capital invested

Capital invested by funds: $487M → $0 (-$487M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 123

Holders
–
Holders Change
-123
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
123
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
-$35.4M
2
BIT
BlackRock Institutional Trust
California
-$31.5M
3
TAL
TIG Advisors LLC
New York
-$30.8M
4
State Street
State Street
Massachusetts
-$30.1M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$27.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
AllianceBernstein
51
AllianceBernstein
Tennessee
– -$1.41M -166,300 Closed
GI
52
GAMCO Investors
Connecticut
– -$1.34M -157,573 Closed
TC
53
TFS Capital
Pennsylvania
– -$1.28M -150,821 Closed
GACM
54
Green Arrow Capital Management
New York
– -$1.25M -147,259 Closed
U
55
UBS
Switzerland
– -$1.19M -140,305 Closed
TA
56
Teachers Advisors
New York
– -$1.14M -133,920 Closed
HM
57
Harvest Management
New York
– -$1.06M -125,000 Closed
RhumbLine Advisers
58
RhumbLine Advisers
Massachusetts
– -$1.05M -123,871 Closed
Nomura Holdings
59
Nomura Holdings
Japan
– -$1.02M -122,691 Closed
PAM
60
Panagora Asset Management
Massachusetts
– -$1.01M -118,591 Closed
SM
61
Sabby Management
Florida
– -$845K -99,703 Closed
SG Americas Securities
62
SG Americas Securities
New York
– -$831K -97,938 Closed
ProShare Advisors
63
ProShare Advisors
Maryland
– -$792K -93,384 Closed
NFA
64
Nationwide Fund Advisors
Ohio
– -$770K -90,760 Closed
FNYS
65
First New York Securities
New York
– -$751K -88,500 Closed
State Board of Administration of Florida Retirement System
66
State Board of Administration of Florida Retirement System
Florida
– -$706K -83,285 Closed
BA
67
BlackRock Advisors
Delaware
– -$701K -82,585 Closed
MLICM
68
Metropolitan Life Insurance Company (MetLife)
New York
– -$698K -82,313 Closed
HCM
69
Highbridge Capital Management
New York
– -$685K -80,602 Closed
PA
70
Pinnacle Associates
New York
– -$678K -79,820 Closed
Swiss National Bank
71
Swiss National Bank
Switzerland
– -$625K -73,700 Closed
Verition Fund Management
72
Verition Fund Management
Connecticut
– -$608K -71,732 Closed
VOYA Investment Management
73
VOYA Investment Management
Georgia
– -$601K -70,914 Closed
Manulife (Manufacturers Life Insurance)
74
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$596 -70,363 Closed
CCMH
75
Cornerstone Capital Management Holdings
New York
– -$566K -66,615 Closed
1 2
3
4 5

ASTX Hedge Fund Activity: Q4 2013 in Review

0 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in ASTEX PHARMACEUTICALS, INC COM (ASTX) for Q4 2013, worth a combined $0 — down 100% from $487M a quarter earlier.

Sellers outnumbered buyers: 123 funds closed out of ASTX and 0 opened new positions — a net loss of 123 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock Fund Advisors, exiting entirely with an estimated $35.4M sold.

  • 0 institutional investors held ASTEX PHARMACEUTICALS, INC COM (ASTX) as of Q4 2013, down from 123 in Q3 2013.
  • Funds reported $0 of ASTEX PHARMACEUTICALS, INC COM stock for Q4 2013, down 100% quarter-over-quarter.
  • 0 funds opened new ASTEX PHARMACEUTICALS, INC COM positions in Q4 2013 and 123 closed out, a net change of -123 holders.
  • The largest ASTEX PHARMACEUTICALS, INC COM seller in Q4 2013 was BlackRock Fund Advisors, an estimated $35.4M sold.

Based on aggregated 13F filings for Q4 2013.